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Abstract 26 
Objective: To critically appraise the measurement properties of standardized health-related 27 
quality of life (HRQOL) instruments for colorectal cancer (CRC) patients, and to provide 28 
recommendations on the choice of HRQOL instruments. 29 
Study Design and Setting: Systematic review of English-language literature published 30 
between January 1985 and May 2014 identified through a database search of Pubmed, Web 31 
of Science, Embase, and OVID Medline. HRQOL instruments were rated on methodological 32 
quality and overall levels of evidence using a COSMIN checklist. 33 
Results: Internal consistency and hypothesis testing were evaluated most frequently in 63 34 
studies identified. The Functional Assessment of Cancer Therapy-Colorectal (FACT-C) was 35 
the most extensively evaluated. The highest number of positive ratings in the overall level of 36 
evidence was found in the colorectal cancer-specific quality of life questionnaire module 37 
(QLQ-CR38) in European Organization for Research and Treatment of Cancer (EORTC) 38 
module, followed by the Memorial Sloan Kettering Cancer Center (MSKCC) Bowel 39 
instrument, FACT-C and Quick-FLIC. The EORTC QLQ-CR38 had the most positive ratings 40 
on measurement property and was recommended. 41 
Conclusion: The EORTC QLQ-CR38 was recommended to assess HRQOL in patients with 42 
CRC, regardless of disease stage and primary tumour site.  43 
Running Title: Recommendation for HRQOL Instruments in CRC 44 
Keywords: systematic review; colorectal cancer; quality of life, measurement property, 45 
psychometrics; COSMIN 46 
 47 
JCE Manuscript Table 20140911 clean  Page 2 of 33 
Running Title: Recommendation for HRQOL Instruments in CRC 
  48 
JCE Manuscript Table 20140911 clean  Page 3 of 33 
Running Title: Recommendation for HRQOL Instruments in CRC 
Abbreviations: CRC=colorectal cancer; HRQOL=health-related quality of life; 49 
MESH=Medical Subject Heading; COSMIN=Consensus-based Standards for the selection of 50 
health Measurement Instruments; PRISMA=Preferred Reporting Items for Systematic 51 
Reviews and Meta-Analyses; ICC=intraclass correlation coefficient; EORTC=European 52 
Organization for Research and Treatment of Cancer; QLQ=Quality-of-Life Questionnaire; 53 
FACIT=Functional Assessment of Chronic Illness Therapy; FACT-G=Functional 54 
Assessment of Cancer Therapy-General; FACT-C=Functional Assessment of Cancer 55 
Therapy-Colorectal; FCSI-9=Functional Assessment of Cancer Therapy Colorectal Symptom 56 
Index; FACIT-F=Functional Assessment of Chronic Illness Therapy-Fatigue; FLIC=Functional 57 
living index for cancer; GIQLI=Gastrointestinal Quality of Life Index; RSCL-M=Modified 58 
Version of Rotterdam Symptom Checklist; MSAS-SF=Memorial Symptom Assessment 59 
Scale; CMSAS=Condensed MSAS; FIQL=Fecal Incontinence Quality of Life; mCOH-QOL-60 
Ostomy=Modified City of Hope Ostomy questionnaire; SRQS=Social Relational Quality 61 
Scale; MSKCC=Memorial Sloan Kettering Cancer Centre; CRQ=Cancer Rehabilitation 62 
Questionnaire; HLQ=Herdecke Quality of Life questionnaire; QLACS=Quality of Life in 63 
Adult Cancer Survivors; MACFS= Modified Ambulatory Care Flow Sheet; Mini-MAC 64 
Scale= Mini-Mental Adjustment to Cancer Scale; QLICP-GM=Quality of Life Instruments 65 
for Cancer Patients-General Module; QLICP-GM=Quality of Life Instruments for Cancer 66 
Patients-General Module; QLICP-CR=Quality of Life Instruments for Cancer Patients-67 
Colorectal Cancer; EQ-5D=EuroQol-5 dimension 68 
 69 
70 
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What is new? 71 
 72 
Key finding: 73 
- The EORTC QLQ-CR38 had the greatest number of positive ratings and the most 74 
positive ratings on measurement property according to quality assessment criteria  75 
- The EORTC QLQ-CR38 was recommended to measure HRQOL in patients with 76 
CRC, regardless of disease stage and location of primary tumour site. 77 
 78 
What this adds to what was known: 79 
- There is a shortage of a perfect methodological quality for measurement property of 80 
HRQOL instrument used in CRC patients, despite large amount of instruments 81 
available. 82 
 83 
What is the implication, what should change now: 84 
- There is a need for an improvement in the reporting quality of measurement 85 
properties in newly developed or translated instruments. Efforts on the universal 86 
consensus on whether the measurement properties met the acceptable quality criteria, 87 
especially construct validity and responsiveness, should be commenced. 88 
  89 
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Manuscript Text 90 
 91 
Introduction 92 
 93 
Colorectal cancer (CRC) is one of the major cancer deaths worldwide [1], being the 94 
third leading cause of cancer death in the US [2, 3] Previous studies suggested that there is an 95 
growing trend of colorectal cancer incidence rates in some economically developing 96 
countries that involves a rapid transition in dietary style and exercise patterns [2, 3]. 97 
Emerging medical treatment of CRC has contributed to the extension on prolonged survivals. 98 
In addition to disease survivals, health-related quality of life (HRQOL) is becoming standard 99 
outcome measurement of the impact of illness and treatment for CRC in clinical care and 100 
research. Among cancer survivors living with disease, certain aspects of HRQOL (i.e. 101 
physical, psychological, social, etc.) were challenged by the impairment in the ability to 102 
perform daily activities and the presentation of symptoms arising from disease and 103 
treatment[4]. The appropriate usage and adoption of instruments to evaluate HRQOL were 104 
considered important for the better assessment of rehabilitation needs and treatment benefits 105 
from the standpoint of patients, clinicians and health policy makers[5]. 106 
 107 
Classical literature of HRQOL has classified instruments [6, 7] into two major types: 108 
generic and condition-specific (or disease-specific) instruments. Generic instruments are 109 
designed for assessing HRQOL in a wide range of clinical settings and utilized in various 110 
areas of health conditions in a population. They allowed for cross-cultural and international 111 
comparisons of HRQOL from one population to another. Condition-specific instruments 112 
measure more aspects unique to the HRQOL in patients with specific condition, and have 113 
generally been reported to be more responsive than generic instruments [8]. Measurement 114 
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properties are important to support the evidence-based selection of the best instrument for a 115 
particular purpose or population, and quality assurance criteria[9] have been recommended 116 
by Scientific Advisory Committee of the Medical Outcomes Trust[10]. Comprehensive 117 
quality assessment of measurement properties for available HRQOL instruments is presented 118 
based on a wide range of cancer populations[11-13] but there is little evidence concerning 119 
HRQOL instruments in colorectal cancer (CRC) [14]. In spite of multiple instruments had 120 
developed for the measurement of HRQOL in patients with CRC, clinicians and researchers 121 
urged for the most recommended and appropriate HRQOL instruments under a 122 
comprehensive process of psychometric quality assessment. A recent literature review[15] 123 
across a wide range of HRQOL instruments administered in CRC patients, sourcing from 124 
Ovid searching engine and several key journals, recommended SF-12 for generic measure, 125 
EQ-5D for preference-based measure and European Organization for Research and Treatment 126 
of Cancer Core Quality-of-Life Questionnaire (QLQ-C30) and Functional Assessment of 127 
Cancer Therapy-Colorectal (FACT-C) for condition-specific measures. The aforementioned 128 
review was, however, limited by the inclusion of studies with English-speaking populations 129 
only. Papers concerning the target population of other language speakers were still relevant. 130 
Yet, no systematic review synthesized evidence on the critical appraisal of the measurement 131 
properties of generic and condition-specific HRQOL instruments that have been validated for 132 
use in patients with CRC. The aim of this paper was to conduct a systematic literature review 133 
on the measurement properties of standardized HRQOL instruments for CRC, providing 134 
recommendations on the HRQOL instrument through collective evidence from previous 135 
studies.  136 
 137 
Methods 138 
 139 
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Literature Search Methods  140 
 141 
Search Engines and Strategies 142 
 143 
A series of systematic literature search was conducted in databases of PubMed, Web 144 
of Science using Web of Knowledge platform, Embase and MEDLINE using OVID 145 
searching platform, to identify studies that investigated the HRQOL of colorectal neoplasm 146 
patients. The Medical Subject Heading (MESH) ‘quality of life’ was combined with ‘colon 147 
neoplasm’, ‘colon cancer’, ‘rectal cancer’, ‘rectal neoplasm’ and ‘colorectal cancer’. Studies 148 
were limited to English language, and the years between January 1985 and May 2014. The 149 
earliest year was chosen as 1985 because the conceptual framework of health-related quality 150 
of life emerged around mid of 1980s[16]. Systematic searches were conducted in May 2014 151 
with electronic search strategies shown in Appendix 1. No additional hand search was done. 152 
After the initial check for duplicated articles, the abstracts of remaining articles were 153 
screened to rule out the introductories, editorials, letters, commentaries, study protocols, case 154 
reports, pure literature reviews and meta-analyses, conference `proceedings, past and current 155 
clinical guidelines and recommendations that were not recognized as original articles. 156 
Articles were also excluded if no abstract available. 157 
 158 
Inclusion and Exclusion Criteria 159 
 160 
After the review of the full-text of screened articles, the eligibility criteria of studies 161 
were 1) to involve original articles 2) to use standardized HRQOL instruments with items 162 
rating on point Likert scales or on linear analogue scales, 3) to carry out in human subjects 163 
and 4) to evaluate the measurement properties of HRQOL instruments in a mixture of CRC 164 
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patients (i.e. CRC with other types of cancer). Articles without available full-text were 165 
excluded. Two reviewers (CW and JC) independently screened the eligibility criteria of study 166 
titles, abstracts, selected full-texts, and reference lists of the studies retrieved by the literature 167 
search. To standardize the appraisal criteria amongst reviewers, the methodological quality of 168 
the included studies was assessed using the Consensus-based Standards for the selection of 169 
health Measurement Instruments (COSMIN) checklist [14, 17, 18] which was previously 170 
adopted for the evaluation of oncological HRQOL instruments[11]. Assessment of the 171 
methodological quality per property was performed by two reviewers independently. 172 
Disagreements regarding the procedures of database search, study selection and eligibility 173 
were resolved by discussion.  174 
 175 
Quality Criteria of Measurement Properties 176 
 177 
According to the international consensus COSMIN taxonomy and definitions[17], the 178 
review evaluated nine measurement properties including: 1) internal consistency, 2) 179 
reliability, 3) measurement error, 4) content validity, 5) structural validity, 6) hypothesis 180 
testing, 7) cross-cultural validity, 8) criterion validity, and 9) responsiveness. The first three 181 
measurement properties are in the subset of reliability category, whereas the subsequent six 182 
measure properties are contained in the validity category. Internal consistency was supported 183 
if the Cronbach’s alpha was equal to or greater than 0.70 and the factor analysis was 184 
conducted with adequate sample size for the support of unidimensionality of the scales. 185 
Reliability was supported if the test-retest reliability coefficient represented by intraclass 186 
correlation coefficient (ICC) and weighted kappa was equal to or greater than 0.70 between 187 
two administrations over short period of time among subjects with stable health condition. 188 
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Measurement error was considered adequate if the smallest detectable change was smaller 189 
than the minimal important change, or if the minimal important change reached the limits of 190 
agreement. Content validity was supported if the target population considers all items in the 191 
questionnaire to be relevant and the questionnaire to be complete. Structural validity was 192 
considered to be adequate if the factors explained at least 50% of the total variance. 193 
Hypothesis testing was assessed by testing a priori hypotheses specific to the expected 194 
correlations between scores representing similar concepts or expected differences in scores 195 
between known groups. Cross-cultural validity was supported if the original factor structure 196 
was confirmed or there was no important differential item functioning between language 197 
versions. Criterion validity was considered to be present if the gold standard for HRQOL 198 
measure existed as the full-length version and tested for the correlations with the shortened 199 
version of the instrument. Responsiveness was examined using different statistics to detect 200 
important changes over time.  201 
 202 
Data Synthesis on Methodological Quality Evaluation 203 
 204 
For each study, each measurement property was rated as ‘adequate’ (+, positive sign) 205 
or ‘not adequate’ (-, negative sign) if the quality criterion was met or was not met for each 206 
measurement property respectively. If the information given to the measurement property 207 
was unclear or ambiguous, it was rated as ‘doubtful’ (?). Given no information was found on 208 
that measurement property, zero (0) rating was assigned to that quality assessment. The 209 
measurement properties of HRQOL instruments were evaluated based on the explicit quality 210 
criteria proposed by Terwee et al.[9, 19]. A summary of the quality criteria for measurement 211 
properties of HRQOL instruments is presented in the Appendix 2. 212 
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 213 
Furthermore, the quality criteria of each measurement property were accompanied 214 
with the level of evidence scoring on a 4-point Likert scale in an ascending order of ‘poor’, 215 
‘fair’, ‘good’ or ‘excellent’. To consolidate the grading of measurement properties of multiple 216 
instruments, the overall rating for a measurement property was synthesized by taking the 217 
quality ratings of each measurement property, consistency of results between studies, and its 218 
evidence level for measurement properties. One of the five possible rating options 219 
representing ‘unknown’ (?), ‘conflicting’ (+/-), ‘limited’ (+ or -), ‘moderate’ (++ or --) or 220 
‘strong’ (+++ or ---) were assigned if the measurement property of instrument was graded at 221 
least one. Rating summary of the overall levels of evidence for the quality of each 222 
measurement property is displayed in Appendix 3. 223 
 224 
Results 225 
Figure 1 shows the process of literature identification, screening for eligibility and 226 
selection of studies during the literature search presented in a Preferred Reporting Items for 227 
Systematic Reviews and Meta-Analyses (PRISMA) flow diagram [20]. The literature search 228 
was completed in June 2014 and identified a total of 7553 potentially relevant studies 229 
(PubMed: 1349; Web of Science: 2318; MEDLINE: 1735; Embase: 2151) that met the 230 
searching criteria in four bibliographic databases. After the removal of duplicated (n=3332) 231 
and non-original articles (n=1439) by abstract screening, the abstract content of 2782 studies 232 
were reviewed for eligibility. The full-text articles of all (n=65) eligible studies were 233 
reviewed. The earliest study that assessed measurement properties of HRQOL instruments 234 
relevant to CRC patients was published in 1993. We found 63 studies which investigated the 235 
measurement properties of HRQOL instruments in CRC patients or in a variety of cancer 236 
patients including CRC patients. 237 
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 238 
This review identified 3 generic and 34 condition-specific instruments: six 239 
instruments in EORTC module, seven instruments in FACIT module and 21 instruments in 240 
other modules. All identified instruments were evaluated by whether the psychometric 241 
properties met the quality criteria. The names of instruments in each module are shown in 242 
Table 1. The Functional Assessment of Cancer Therapy-Colorectal (FACT-C) was the most 243 
evaluated HRQOL instrument. The second most evaluated instrument was QLQ-CR38[21-27] 244 
which was evaluated by seven studies.  General characteristics of the HRQOL instruments 245 
and the respective measurement properties evaluated are summarized in Appendix 4. Some of 246 
HRQOL instruments evaluated was designed for CRC patients exclusively (14/37, 37.8%) 247 
whereas a majority of them was designed for a wide range of cancer patients or patients with 248 
colostomy or ileostomy (23/37, 62.1%). The total number of items varied from five to 47 249 
whilst the number of subscales or domains varied from one (unidimensional) to 12. The 250 
response options were predominantly a 4-point or 5-point Likert scale. 251 
 252 
Characteristics of included instruments 253 
Characteristics of the 63 studies included in this review were reported in Appendix 5. 254 
Forty-one studies were originated from countries located in North America and Europe [5, 7, 255 
23-25, 27-54] and the rest of them were conducted in Asian countries. Most of the 256 
instruments were evaluated in the language versions of English, French and German. Four 257 
studies reported the measurement properties of instruments were translated to more than one 258 
language versions and evaluated in CRC patients recruited from the respective countries [33, 259 
46, 50, 54].  260 
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Thirty-five studies focused on CRC patients solely, ranging from patients with liver 262 
metastatic CRC to patients undergoing surgery [21-27, 33-35, 39, 42, 45, 46, 50, 52, 54-62], 263 
16 studies assessed patients with CRC and other diseases, including breast, ovarian or 264 
prostate cancer [28-30, 43, 44, 51, 59, 63-67]. The remaining nine studies were mostly 265 
targeted at patients suffering from rectal cancer, ostomy or unspecified or mixed types of 266 
cancer [7, 31, 36-38, 40, 41, 47, 49, 53, 68-71].   267 
 268 
The stage of diseases was also different in the selected studies. Twenty-five of the 269 
studies included patients from stage one to four according to American Joint Committee on 270 
Cancer classification system[23, 24, 27, 28, 30, 32-34, 42, 44, 45, 51, 52, 54, 55, 57, 58, 65-271 
67] and patients in these studies were largely over 60 years old. 272 
 273 
Methodological Quality of Each Study 274 
 275 
Each eligible study was assessed on nine measurement properties based on the 276 
aforementioned criteria on a 4-point Likert Scale, ranging from ‘excellent’ to ‘poor’. Details 277 
of the measurement properties of each study are summarized in Table 2. The three most 278 
frequently reported properties were hypothesis testing (58 studies reported), structural 279 
validity (56 studies reported) and internal consistency (49 studies reported), whilst 280 
measurement error (1 study reported), criterion validity (8 studies reported) and cross-cultural 281 
validity (11 studies reported) were the three least addressed ones. The best performed area 282 
was content validity with 10 out of 12 articles reported achieved excellent quality. However, 283 
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more than half of the articles reported internal consistency (55.1%), structural validity 284 
(64.3%), cross-cultural validity (72.7%) and criterion validity (62.5%) were found to have 285 
poor methodological quality.  286 
 287 
Overall quality of measurement properties 288 
 289 
Table 3 summarizes the overall levels of evidence per measurement property and 290 
HRQOL instrument. None of the HRQOL instruments has been evaluated and rated on all the 291 
nine measurement properties recommended by the quality assessment criteria. Most of the 292 
instruments provided information on internal consistency, structural validity, and hypothesis 293 
testing. Measurement error, cross-cultural validity, and criterion validity were only assessed 294 
in a minority of instruments as limited information was found in these studies. Two 295 
instruments, QLQ-CR38 [21-27] and FACT-C [23, 27, 33, 34, 55, 59-61] were the most 296 
evaluated instruments with each of them had eight reviewed measurement properties. Among 297 
all the assessed items, FACT-G (Version 2) [7], FACT-G (Version 3) [29] and mCOH-QOL-298 
Ostomy [37-39] were the instruments scored limited to strong positive evidence on all their 299 
measured properties without any negative or uncertain rating.  Seven evaluated instruments 300 
were found to have at least one negative rating in any one of their reviewed measurement 301 
properties (Version 3 of QLQ-C30 [27, 29, 30, 65, 66], Coping with CRC [58], Quality-302 
Quantity Questionnaire [43], Mini-MAC Scale [49], SF-12 (Version 2) [60], EQ-5D [72] and 303 
SF-6D [73]).   304 
Internal Consistency  305 
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Thirty-one instruments were assessed on this property. QLQ-C30 (Version 3)[27, 29, 306 
30, 65, 66], FACT-G (Version 3) [5, 29], Quick-FLIC[63] and Modified FIQL [70] were 307 
rated as strong positive and none of the instruments were rated negative. 308 
Reliability 309 
Seventeen instruments were assessed on this property where seven were rated as 310 
limited positive (Version 3 of QLQ-C30 [5, 27, 30, 65, 66], Version 2 of FACT-G [7], 311 
Version 4 of FACT-G [23, 27, 69], FACT-C [23, 27, 33, 34, 55, 59-61], QLICP-GM [67], 312 
QLICP-CR [62] and MSKCC Bowel Function [40, 41]). Quick-FLIC [63] was the only 313 
instrument that was rated as strong positive by the criteria.  314 
Measurement Error  315 
Only one instrument (FACT-C) [23, 27, 33, 34, 55, 59-61] was assessed on this 316 
property and rated as limited positive.  317 
Content Validity  318 
Twelve instruments were assessed on this property and ten of them  (QLQ-CR38 [21-319 
27], QLQ-LMC21 [46, 50], QLQ-SWB36[53], Version 2 of FACT-G [32], FACT-C [23, 27, 320 
33, 34, 55, 59-61], QLICP-GM [67], mCOH-QOL-Ostomy [37-39], MSKCC Bowel 321 
Function[40, 41], Coping with CRC [58], QLACS [44]) were rated as strong positive. Two 322 
instruments (CRQ [42] and QLICP-CR [62]) were rated as unknown.  323 
Structural Validity 324 
Thirty-two instruments were assessed on this property but only nine were rated as 325 
limited to moderate positive (QLQ-CR38 [21-27], Version 2[32] and Version 3[29] of 326 
FACT-G, mCOH-QOL-Ostomy [37-39], SRQS [57], MSKCC Bowel Function [40, 41], 327 
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Coping with CRC [58], HLQ [51], QLACS [44]). The rest of them were rated as unknown, 328 
and one item (Quality-Quantity Questionnaire [43]) was rated as limited negative. 329 
Hypothesis Testing 330 
 Thirty-two instruments were rated on this property with eleven rated as strong 331 
positive (Version 1 of QLQ-C30 [28, 64], Version 3 of QLQ-C30 [5, 27, 30, 65, 66], QLQ-332 
CR38 [21-27], QLQ-LMC21 [46, 50], Version 4 of FACT-G [23, 27, 69], FACT-C [23, 27, 333 
33, 34, 55, 59-61], FCSI-9 [35], FACIT-F [68], QLICP-CR [62], MSKCC Bowel 334 
Function[40, 41] and EQ-5D [72]).  335 
Cross-cultural validity 336 
 All ratings given to the nine instruments which were assessed on this property 337 
(Version 3 of QLQ-C30 [27, 29, 30, 65, 66], QLQ-SWB36 [53], QLQ-CR38 [21-27], QLQ-338 
CR29 [31, 54], FACT-C [23, 27, 33, 34, 55, 59-61], MSAS-SF [56], CMSAS [56], SRQS 339 
[57], MSKCC Bowel Function [40, 41]) were unknown as inadequate information was 340 
provided by these studies. 341 
Criterion Validity 342 
 Eight instruments were assessed on this property with only two instruments, QLQ-343 
LMC21 [46, 50] and FACT-G7 [71] were rated as moderate positive. The rest of them were 344 
rated as unknown due to unclear methodological quality.  345 
Responsiveness  346 
Fourteen instruments were assessed on this property and only one instrument was 347 
rated strong positive (FCSI-9 [35]), whilst three instruments were rated as moderate positive 348 
(QLQ-CR38 [21-27], FACT-G (Version 4) [23, 27, 69] and FACT-C [23, 27, 33, 34, 55, 59-349 
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61]) and other three moderate negative (Version 3 of QLQ-C30 [5, 27, 30, 65, 66], SF-12 350 
(Version 2) [60] and SF-6D [73]).  351 
 352 
Discussions 353 
 354 
This systematic review evaluated the measurement properties of 37 standardized HRQOL 355 
instruments used in CRC patients among 63 eligible studies identified in the full-text 356 
assessment stage. None of the instruments were adequately evaluated for all nine 357 
measurement properties recommended by COSMIN[17]. Compared to other instruments, 358 
EORTC QLQ-CR38 and FACT-C were more comprehensively evaluated as each of them 359 
obtained eight ratings in all of the nine measurement properties. Moreover, the number of 360 
positive sign as an indication of satisfactory performance of measurement property was 361 
obtained to compare the overall performance of the 37 instruments. QLQ-CR38 in EORTC 362 
module received the highest number (‘+’: 14) of positive signs among all the instruments, 363 
followed by MSKCC Bowel Function (‘+’: 11), FACT-C (‘+’: 10) and Quick-FLIC (‘+’: 10).  364 
MSKCC bowel function was limited for the designed for the measurement of HRQOL in 365 
rectal cancer. While the QLQ-CR38 and FACT-C were the most assessed instruments in our 366 
review, QLQ-CR38 seized more positive ratings and had a better rating in internal 367 
consistency and structural validity than the FACT-C. Therefore, current review suggested 368 
that QLQ-CR38 was the most comprehensive and positive rated instrument in this review, 369 
with positive ratings in internal consistency, reliability, content validity, structural validity, 370 
hypothesis testing and responsiveness. Despite the QLQ-CR38 was not assessed on 371 
measurement error and rated unknown on both cross-cultural validity and criterion validity, 372 
these three properties were either not evaluated or rated as unknown for other instruments. 373 
Aside from the highest number of positive sign, the measurement properties of QLQ-CR38 374 
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were evaluated by seven studies, greater than two studies for MSKCC bowel function 375 
instrument and one study for Quick-FLIC. Though FACT-G (Version 2) was rated as positive 376 
on the same properties rated for the QLQ-CR38, the ratings were generally poorer than those 377 
for the latter. The QLQ-CR38 was therefore recommended regardless of disease stage and 378 
location of primary tumour site because of its positive performance on most of the assessed 379 
properties.  380 
 381 
In line with another structured review evaluated for CRC patients in the UK[15], the 382 
measurement properties of generic instruments among CRC patients was identified in current 383 
systematic review. The methodological evaluation of that structured review[15] 384 
recommended the use of two generic instruments, EQ-5D and SF-12, and two condition-385 
specific instruments, QLQ-C30 and FACT-C, based on eight categories of appraisal criteria 386 
that were used in earlier studies[13]. Unlike current systematic review, not all studies selected 387 
in previous review were aimed and dedicated to demonstrate the measurement properties of 388 
HRQOL instruments. It was worthwhile noting that the study selection criteria and the 389 
appraisal criteria in current review differed from with that in previous review. For instance, in 390 
case of methodological quality of responsiveness property of HRQOL instruments, COSMIN 391 
checklist focused on the detailed description of gold standard or comparator instrument that 392 
indicated the responsiveness property whereas the appraisal criteria applied in previous 393 
review focused on the statistically significant changes in HRQOL scores over time. 394 
 395 
The EORTC and FACIT groups of instruments shared the same evolvement of a few 396 
versions through long-lasting transitions and variations in the item wordings, item responses, 397 
scale structure, and scoring algorithm. In EORTC modules based on their group website, the 398 
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QLQ-CR38 and version 1 of QLQ-C30 was superseded by the shortened QLQ-CR29 and 399 
version 3 of QLQ-C30, respectively. The QLQ-CR38 and version 3 of QLQ-C30 were rated 400 
better HRQOL instrument than the QLQ-CR29 and superseded version of QLQ-C30, 401 
possibly due to the substantive amount of measurement property evaluation for QLQ-CR38 402 
and version 3 of QLQ-C30 over the past two decades. Nevertheless, the currently available 403 
version of QLQ-CR29 was not rated more adequate than QLQ-CR38, in part explained by the 404 
fact that the first publication year of latter one was in 1999, at least one decade earlier than 405 
the end of search date in current review. Possible explanation was likely to be extrapolated to 406 
the FACIT modules, in the situation when the version 2 and 3 of FACT-G were superseded 407 
by its version 4 which was firstly introduced in year 2003[74]. The instruments deserved 408 
significant advantages on their overall levels of evidence when the instruments have been 409 
developed at least ten years up to the search date in current review. Among the 39 eligible 410 
studies, the HRQOL instruments developed by EORTC and FACIT modules were directly 411 
compared and contrasted in three studies in France [23, 27, 29]. Aside from the one study [27] 412 
limited by small sample size (n<30), the rest of them reported the acceptability and 413 
preference of instruments in two groups in addition to the measurement properties of 414 
instruments. CRC patients elicited patient preference for core HRQOL instruments of two 415 
modules, and preferred the QLQ-C30 over the FACT-G and FLIC instruments in part 416 
reflecting their response burden and completion time (7.9 vs 10.2 vs 8.4 minutes, 417 
respectively)[29]. Likewise, in light of comparing the patient preference for the QLQ-CR38 418 
and FACT-C instruments, no preference difference between QLQ-C30 in supplement with 419 
QLQ-CR38 and FACT-C was observed[23].  420 
 421 
It is noteworthy to point out that included studies of measurement property evaluation 422 
had two major shortcomings of quality criteria reporting. Firstly, the CRQ and Quality-423 
JCE Manuscript Table 20140911 clean  Page 19 of 33 
Running Title: Recommendation for HRQOL Instruments in CRC 
Quantity Questionnaire [42, 43] did not present a priori hypothesis for testing the construct 424 
validity although construct validity has been introduced in the included studies. Secondly, 425 
data on responsiveness were lacking. Out of 22 studies that had investigated responsiveness, 426 
seven studies were rated as ‘poor’ in methodological quality of responsiveness property [21, 427 
45, 46, 54, 62, 66, 67] in part due to the controversy over whether the mean change exceeded 428 
the minimum clinically important difference or discriminated between groups defined by 429 
anchor using area under the curve. Besides, the methodological quality were rated as ‘poor’ 430 
in the evaluation of properties of internal consistency, structural validity and cross-cultural 431 
validity with a lack of details on the factor analysis or item response theory test employed. 432 
Further studies investigating measurement properties of instruments are necessary to 433 
adequately report clear priori hypothesis for construct validity and statistics for 434 
responsiveness. Standard reporting of factor analysis is also recommended to provide 435 
comprehensive information for researchers to review the reliability and validity of the 436 
instruments.  437 
 438 
Limitations 439 
A plausible limitation of this review aroused from the process of literature search and 440 
selection of studies. Abstracts from conference were also precluded in this review which 441 
implies that not all the CRC studies that had used HRQOL were included. Besides, several 442 
instruments (e.g. FCSI-9 [35]) were only used in one or a few studies, which may not be 443 
supportive enough to provide reliable evidence to the instruments being evaluated. Further 444 
studies are recommended to ensure the evidence comparing different HRQOL instruments is 445 
the most updated and comprehensive. The second limitation is inadequate coverage of 446 
measurement properties suggested by COSMIN checklist. Other uncovered measurement 447 
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criteria, including floor/ceiling effects, predictive validity, and interpretability were useful in 448 
assessing the HRQOL of CRC patients. Alternative checklists for general cancer patients[12, 449 
13, 15] were helpful to provide evidence of quality criteria in HRQOL instruments. However, 450 
the adoption of COSMIN checklist, the standardized and structured guideline, would 451 
facilitate a head-to-head comparison in the measurement properties evidence of HRQOL 452 
instruments between CRC patients and other disease populations. Last but not least, some of 453 
the studies[28-30, 32, 36-38, 44, 51, 64-67, 69] involved in this systematic review were based 454 
on patients with mixed types of cancer, but not limited to CRC only. Studies that involved 455 
CRC patients also did not report sufficient measurement properties. In Nicholas et al.’s study 456 
[42], the level of evidence for nine measurement properties was unknown due to flaw 457 
methodological quality and the lack in reporting. This may confound the results of this 458 
review that targeted on evaluating HRQOL of CRC patients.  459 
 460 
Conclusions 461 
 462 
This systematic review draws out an attention to the shortage of a perfect 463 
methodological quality for measurement property of HRQOL instrument used in CRC 464 
patients, despite large amount of instruments available. There is a need for an improvement in 465 
the reporting quality of measurement properties in newly developed or translated instruments. 466 
Efforts on the universal consensus on whether the measurement properties met the acceptable 467 
quality criteria, especially construct validity and responsiveness, should be commenced. 468 
Concerning our review of HRQOL instruments, the EORTC QLQ-CR38 had the greatest 469 
number of positive ratings according to quality assessment criteria. Concerning with the 470 
number of measurement properties with positive ratings, the EORTC QLQ-CR38 was 471 
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recommended to measure HRQOL in patients with CRC, regardless of disease stage and 472 
primary tumour site. 473 
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 Table 1. Names of each evaluated HRQOL instrument  694 
Abbreviation Full name 
EORTC   
QLQ-C30 Core Quality-of-Life Questionnaire 
QLQ-CR38 Colorectal Cancer-specific Quality-of-Life Questionnaire Module 
QLQ-CR29 Colorectal Cancer-specific Quality-of-Life Questionnaire Module 
QLQ-LMC21 Liver Metastases from Colorectal Cancer-specific Quality-of-Life 
Questionnaire Module 
QLQ-SWB36 Spiritual Wellbeing-specific Quality-of-Life Questionnaire Module  
FACIT  
FACT-G Functional Assessment of Cancer Therapy-General 
FACT-C Functional Assessment of Cancer Therapy-Colorectal 
FCSI-9 Functional Assessment of Cancer Therapy Colorectal Symptom Index 
FACT-G7 Rapid Version of the Functional Assessment of Cancer Therapy-General 
FACIT-F Functional Assessment of Chronic Illness Therapy-Fatigue  
FLIC Functional living index for cancer 
Quick-FLIC Quick-Functional living index for cancer 
RSCL-M Modified Version of Rotterdam Symptom Checklist 
QLICP-GM Quality of Life Instruments for Cancer Patients-General Module 
QLICP-CR Quality of Life Instruments for Cancer Patients-Colorectal Cancer 
GIQLI Gastrointestinal Quality of Life Index 
MSAS-SF Memorial Symptom Assessment Scale-Short Form 
CMSAS Condensed Memorial Symptom Assessment Scale  
Modified FIQL Modified Fecal Incontinence Quality of Life 
mCOH-QOL-Ostomy Modified City of Hope Ostomy questionnaire 
SRQS Social Relational Quality Scale 
MSKCC Bowel 
Function  
Memorial Sloan Kettering Cancer Centre Bowel Function 
CRQ Cancer Rehabilitation Questionnaire 
Coping with CRC Coping with Colorectal Cancer 
Quality-Quantity 
Questionnaire 
Quality-Quantity Questionnaire 
HLQ Herdecke Quality of Life Questionnaire 
QLACS Quality of Life in Adult Cancer Survivors 
Body-image Scale Body-image Scale 
Stoma Care QoL scale Stoma Care Quality of life Scale 
MACFS Modified Ambulatory Care Flow Sheet 
Mini-MAC Scale Mini-Mental Adjustment to Cancer  Scale 
Generic  
EQ-5D EuroQol-5 dimension 
SF-12 (Version 2) Version 2 of the 12-Item Short Form Health Survey 
SF-6D 6-Item Short Form Health Survey 
Note: 
 EORTC=European Organization for Research and Treatment of Cancer; FACIT=Functional 695 
Assessment of Chronic Illness Therapy 696 
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Table 2. Methodological Quality of Each Study per Measurement Property and HRQOL Instrument 
    Measurement Properties 
Instrument/Reference 
Internal 
Consistency Reliability 
Measurement 
error   
Content 
validity 
Structural 
validity 
Hypothesis 
testing 
Cross-cultural 
validity 
Criterion 
validity Responsiveness 
EORTC                     
QLQ-C30 (Version 1)           
 [64]       Poor Good    
 [28] Poor     Poor Excellent     
QLQ-C30 (Version 3)           
 [29] Poor      Poor Good     
 [65] Poor     Poor Good      
 [66] Excellent Fair     Excellent Excellent Poor Poor Poor 
 [30] Good      Good Poor   Good 
 [27]  Fair    Poor Poor   Fair 
QLQ-CR38           
 [24] Poor Poor   Excellent Poor Good   Good 
 [23] Poor Fair    Poor Excellent     
 [22] Poor     Poor Fair     
 [26] Poor Good    Poor Fair Poor  Fair 
 [27]  Fair    Poor Poor   Fair 
 [25] Poor     Poor Excellent    
 [21] Good Fair    Good Excellent  Poor Poor 
QLQ-CR29           
 [54] Poor Good    Poor Good Poor  Poor 
 [31] Poor     Poor Good Poor    
QLQ-SWB36 
 [53]     Excellent   Poor   
QLQ-LMC21           
 [50]     Excellent Poor     
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validity Responsiveness 
 [46] Poor     Poor Excellent  Good Poor 
FACIT           
FACT-G (Version 2)           
 [32] Fair Fair   Excellent Good Fair   Fair 
FACT-G (Version 3)           
 [29] Excellent      Good Good     
FACT-G (Version 4)           
 [23] Poor Fair    Poor Excellent     
 [69] Poor Fair    Poor Good   Good 
 [27]  Fair    Poor Poor   Fair 
FACT-C 
           [33] Poor    Excellent Poor Good Poor  Good 
 [34] Poor  Fair    Good    
 [55] Poor      Poor Excellent Fair     
 [23] Poor Fair    Poor Excellent     
 [27]  Fair    Poor Poor   Fair 
 [59] Poor Fair    Poor Excellent    
 [60]          Good 
 [61]      Excellent Excellent    
FCSI-9 
           [35] Poor Good    Poor Excellent   Excellent 
FACT-G7 
           [71] Poor     Poor Fair  Good  
FACIT-F 
 [68] Poor     Poor Excellent    
Other Condition-specific 
         FLIC 
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 [64] Poor     Poor Good    
 [29] Poor      Poor Good     
Quick-FLIC 
           [63] Excellent Excellent    Poor Good   Good 
RSCL-M 
           [36] Fair      Fair Fair    
QLICP-GM 
           [67] Fair Fair   Excellent Fair Fair  Poor Poor 
QLICP-CR 
 [62] Poor Fair   Poor Poor Excellent  Poor Poor 
GIQLI 
           [52]        Poor Fair     
MSAS-SF 
           [56] Poor     Poor Fair Poor   
CMSAS 
           [56] Poor     Poor Fair Poor   
Modified FIQL 
           [70] Excellent     Excellent Fair    
mCOH-QOL-Ostomy 
           [37] Fair    Excellent Fair Fair    
 [38] Fair     Poor Fair    
 [39] Fair     Poor Fair    
SRQS 
           [57] Good     Good Good Fair   
Stoma Care QoL Scale           
 [47] Good     Excellent Fair    
MACFS           
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 [48]       Fair    
Mini-MAC Scale           
 [49] Fair Fair    Good Fair    
MSKCC Bowel Function  
         
 
[40] Good Poor   Excellent Good Excellent    
[41] Good Fair    Good Excellent Fair   
CRQ 
           [42] Poor Poor   Poor Poor Fair    
Coping with CRC 
          
 
[58] Fair Fair   Excellent Fair Fair  Poor  
Quality-Quantity Questionnaire 
         
 
[43] Fair     Fair Fair    
HLQ 
          
 
[51] Fair Poor    Fair Fair    
QLACS 
          
 
[44] Fair    Excellent Fair Fair  Fair  
Body-image Scale 
            [45] Fair Poor       Fair Fair     Poor 
Generic           
 SF-12 (Version 2)           
 [60]          Good 
 EQ-5D           
 [72]  Fair     Excellent    
 SF-6D           
 [73]          Good 
Note:  Rating of methodological quality according to 4-point Likert scale: Excellent, Good, Fair or Poor. 
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  Measurement Properties   
Instrument 
Internal 
Consistency Reliability 
Measurement 
error   
Content 
validity 
Structural 
validity 
Hypothesis 
testing 
Cross-cultural 
validity 
Criterion 
validity Responsiveness Reference 
EORTC†                       
QLQ-C30 (Version 1) ?     ? +++    [28, 64] 
QLQ-C30 (Version 3) +++ +    ? +++ ? ? -- [27, 30, 65, 
66] 
QLQ-CR38 ++ ++   +++ ++ +++ ? ? ++ [22-27] 
QLQ-CR29 ? ++    ? ++ ?  ? [31, 54] 
            
QLQ-SWB36     +++   ?   [53] 
QLQ-LMC21 ?    +++ ? +++  ++ ? [46, 50] 
FACIT            
FACT-G (Version 2) + +   +++ ++ +   + [32] 
FACT-G (Version 3) +++     ++ ++    [29] 
FACT-G (Version 4) ? +    ? +++   ++ [23, 27, 
69] 
FACT-C ? + +  +++ ? +++ ?  ++ [23, 27, 33, 
34, 55, 59-
61] 
FCSI-9 ? ++    ? +++   +++ [35] 
FACT-G7 ?     ? +  ++  [71] 
FACIT-F ?     ? +++    [68] 
Other Condition-specific            
FLIC ?     ? ++    [64] 
Quick-FLIC +++ +++    ? ++   ++ [63] 
RSCL-M +     ? +    [36] 
QLICP-GM + +   +++ ? +  ? ? [67] 
QLICP-CR ? +   ? ? +++  ? ? [62] 
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Cross-cultural 
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validity Responsiveness Reference 
GIQLI      ? +    [52] 
MSAS-SF ?     ? + ?   [56] 
CMSAS ?     ? + ?   [56] 
Modified FIQL +++     ? +    [70] 
mCOH-QOL-Ostomy +    +++ + +    [37-39] 
SRQS ++     ++ ++ ?   [57] 
Stoma Care QoL scale ++     ? +    [47] 
MACFS       +    [48] 
Mini-MAC Scale  + -    -- +    [49] 
MSKCC Bowel 
Function 
++ +   +++ ++ ++ ?   [40, 41] 
CRQ ? ?   ? ? ?    [42] 
Coping with CRC + -   +++ + +  ?  [58] 
Quality-Quantity 
Questionnaire 
+     - ?    [43] 
HLQ + ?    + +    [51] 
QLACS +    +++ + +  ?  [44] 
Body-image Scale + ?       ? +     ? [45] 
Generic            
SF-12 (Version 2)          -- [60] 
EQ-5D  -     +++    [72] 
SF-6D          -- [73] 
Note:               
    Overall levels of evidence: +++/--- , strong evidence positive/negative result;  ++/-- , moderate evidence positive/negative result;  +/- , limited evidence 
positive/negative result; ?, unknown due to poor methodological quality. 
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